Search Results - "Du Mond, Charles"

Serum Potassium and Short-term Clinical Outcomes Among Hemodialysis Patients: Impact of the Long Interdialytic Interval by Brunelli, Steven M., MD, MSCE, Du Mond, Charles, PhD, Oestreicher, Nina, PhD, Rakov, Viatcheslav, MD, Spiegel, David M., MD

“…Background Hyperkalemia is common among hemodialysis patients and is associated with morbidity and mortality. The long interdialytic interval is likewise…”
Get full text

Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease by Pitt, Bertram, Bushinsky, David A., Kitzman, Dalane W., Ruschitzka, Frank, Metra, Marco, Filippatos, Gerasimos, Rossignol, Patrick, Du Mond, Charles, Garza, Dahlia, Berman, Lance, Lainscak, Mitja

“…Aims Hyperkalaemia risk precludes optimal renin–angiotensin–aldosterone system inhibitor use in patients with heart failure (HF), particularly those with…”
Get full text

Amphotericin B Colloidal Dispersion vs. Amphotericin B as Therapy for Invasive Aspergillosis by Mary H. White, Elias J. Anaissie, Shimon Kusne, John R. Wingard, John W. Hiemenz, Cantor, Alan, Marc Gurwith, Charles Du Mond, Richard D. Mamelok, Raleigh A. Bowden

“…To assess the efficacy and safety of amphotericin B colloidal dispersion (ABCD), 82 patients with proven or probable aspergillosis who were treated in clinical…”
Get full text

Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients by Brunelli, Steven M, Spiegel, David M, Du Mond, Charles, Oestreicher, Nina, Winkelmayer, Wolfgang C, Kovesdy, Csaba P

“…A high serum-to-dialysate potassium (K+) gradient at the start of dialysis leads to rapid lowering of serum K+ and may confer a greater risk of adverse events…”
Get full text

Ganciclovir Treatment of Cytomegalovirus Colitis in AIDS: A Randomized, Double-Blind, Placebo-Controlled Multicenter Study by Dieterich, Douglas T., Kotler, Donald P., Busch, David F., Crumpacker, Clyde, Du Mond, Charles, Dearmand, Bernadette, Buhles, William

“…The efficacy and safety of ganciclovir therapy for cytomegalovirus (CMV) colitis in patients with AIDS was examined in a double-blind, placebo-controlled…”
Get full text

Effect of Patiromer on Urinary Ion Excretion in Healthy Adults by Bushinsky, David A, Spiegel, David M, Gross, Coleman, Benton, Wade W, Fogli, Jeanene, Hill Gallant, Kathleen M, Du Mond, Charles, Block, Geoffrey A, Weir, Matthew R, Pitt, Bertram

“…Patiromer is a nonabsorbed potassium-binding polymer that uses calcium as the counterexchange ion. The calcium released with potassium binding has the…”
Get full text

MP709COMPARISON OF POTASSIUM VALUES BEFORE AND AFTER PATIROMER INITIATION AMONG PATIENTS RECEIVING CHRONIC HEMODIALYSIS IN THE UNITED STATES by Rowan, Christopher, Kovesdy, Csaba, Du Mond, Charles, Oestreicher, Nina, Spiegel, David, Winkelmayer, Wolfgang

Get full text

TO028EFFECT OF PATIROMER ON SERUM POTASSIUM IN HYPERKALEMIC PATIENTS WITH SEVERE CKD ON RAAS INHIBITORS: RESULTS FROM OPAL-HK AND AMETHYST-DN by Bushinsky, David, Romero, Alain, Du Mond, Charles, Mayo, Martha, Ketteler, Markus

Get full text

Results of the Phase 3 VITAL Study of NEOD001 (Birtamimab) Plus Standard of Care in Patients with Light Chain (AL) Amyloidosis Suggest Survival Benefit for Mayo Stage IV Patients by Gertz, Morie A, Cohen, Adam D., Comenzo, Raymond L, Du Mond, Charles, Kastritis, Eftathios, Landau, Heather J, Libby, Edward N., Liedtke, Michaela, Merlini, Giampaolo, Sanchorawala, Vaishali, Schönland, Stefan O., Wechalekar, Ashutosh D, Zonder, Jeffrey A., Kinney, Gene

“…BACKGROUND: AL amyloidosis is a rare, progressive, and typically fatal disease caused by both soluble and insoluble (amyloid) forms of misfolded immunoglobulin…”
Get full text

Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers by Lesko, Lawrence J, Offman, Elliot, Brew, Christine Taylor, Garza, Dahlia, Benton, Wade, Mayo, Martha R, Romero, Alain, Du Mond, Charles, Weir, Matthew R

“…Patiromer is a potassium-binding polymer that is not systemically absorbed; however, it may bind coadministered oral drugs in the gastrointestinal tract,…”
Get more information

1-YEAR SAFETY AND EFFICACY OF PATIROMER FOR HYPERKALEMIA IN HEART FAILURE PATIENTS WITH CHRONIC KIDNEY DISEASE ON RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS by Pitt, Bertram, Bushinsky, David, Garza, Dahlia, Stasiv, Yuri, Mond, Charles Du, Berman, Lance, Bakris, George

“…Methods: Multicenter, open-label trial of 304 pts with CKD, DM, HTN and serum K+ (s-K+) >5.0 mEq/L; pts randomized to patiromer starting doses by baseline…”
Get full text

SO008EFFECT OF THE POTASSIUM BINDING POLYMER PATIROMER ON URINE SODIUM EXCRETION IN HEALTHY ADULTS by Bushinsky, David A, Spiegel, David M, Benton, Wade, Fogli, Jeanene, Hill Gallant, Kathleen M, Romero, Alain, Du Mond, Charles, Gross, Coleman, Block, Geoffrey A, Pitt, Bertram

Get full text

1-year safety and efficacy of patiromer for hyperkalemia in heart failure patients with chronic kidney disease on renin-angiotensin-aldosterone system inhibitors by Pitt, Bertram, Bushinksy, David A, Garza, Dahlia, Stasiv, Yuri, Du Mond, Charles, Berman, Lance, Bakris, George

Get full text

Electrical activity from the superior pharyngeal constrictor during reflexive and nonreflexive tasks by Perlman, A L, Luschei, E S, Du Mond, C E

“…The purpose of this investigation was to determine, in a quantitative manner, which, if any, nonswallowing tasks produce significant levels of activation in…”
Get more information

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial by Northfelt, D W, Dezube, B J, Thommes, J A, Miller, B J, Fischl, M A, Friedman-Kien, A, Kaplan, L D, Du Mond, C, Mamelok, R D, Henry, D H

“…Kaposi's sarcoma (KS), the most common neoplasm in patients with AIDS, is a significant clinical problem for which current therapies are frequently…”
Get more information

Early Treatment with Ganciclovir to Prevent Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation by Goodrich, James M, Mori, Motomi, Gleaves, Curt A, Du Mond, Charles, Cays, Monica, Ebeling, Darlene F, Buhles, William C, DeArmond, Bernadette, Meyers, Joel D

“…CYTOMEGALOVIRUS (CMV) infection remains a formidable barrier to allogeneic bone marrow transplantation and continues to cause morbidity and mortality among…”
Get full text

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients : results of a placebo-controlled, double-blind trial by WINSTON, D. J, HO, W. G, BARTONI, K, DU MOND, C, EBELING, D. F, BUHLES, W. C, CHAMPLIN, R. E

“…To evaluate the efficacy and safety of ganciclovir for prevention of cytomegalovirus (CMV) infection and disease. A randomized, placebo-controlled,…”
Get full text

Adaptive robust L-estimates of scale with applications to a test of homogeneity of variances by Du Mond, Charles Edward

“…A method is proposed for robust estimation of scale or spread. Using the results of Yuh's (1984) selector statistics, we construct an adaptive robust…”
Get full text

A Robust Confidence Interval for Location by Du Mond, Charles E., Lenth, Russell V.

“…Robust estimation procedures have been the subject of a large number of comparative studies. Less attention has been paid to confidence intervals and tests…”
Get full text

A Robust Confidence Interval for Location by Mond, Charles E. Du, Lenth, Russell V.

Get full text